SEARCH

SEARCH BY CITATION

References

  • 1
    Bonthron DT, Handin RI, Kaufman RJ, Wasley LC, Orr EC, Mitsock LM, Ewenstein B, Loscalzo J, Ginsburg D, Orkin SH (1986) Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature 324:270273.
  • 2
    Sadler JE (1998) Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67:395424.
  • 3
    Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289297.
  • 4
    Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS (1986) von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem 261:381385.
  • 5
    Fujimura Y, Titani K, Holland LZ, Roberts JR, Kostel P, Ruggeri ZM, Zimmerman TS (1987) A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem 262:17341739.
  • 6
    Pietu G, Meulien P, Cherel G, Diaz J, Baruch D, Courtney M, Meyer D (1989) Production in Escherichia coli of a biologically active subfragment of von Willebrand factor corresponding to the platelet glycoprotein Ib, collagen and heparin binding domains. Biochem. Biophys Res Commun 164:13391347.
  • 7
    Sugimoto M, Ricca G, Hrinda ME, Schreiber AB, Searfoss GH, Bottini E, Ruggeri ZM (1991) Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli. Biochemistry 30:52025209.
  • 8
    Gralnick HR, Williams S, McKeown L, Kramer W, Krutzsch H, Gorecki M, Pinet A, Garfinkel LI (1992) A monomeric von Willebrand factor fragment, Leu-504–Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX. Proc Natl Acad Sci USA 89:78807884.
  • 9
    Azuma H, Dent JA, Sugimoto M, Ruggeri ZM, Ware J (1991) Independent assembly and secretion of a dimeric adhesive domain of von Willebrand factor containing the glycoprotein Ib-binding site. J Biol Chem 266:1234212347.
  • 10
    Cruz MA, Handin RI, Wise RJ (1993) The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem 268:2123821245.
  • 11
    Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, Lopez JA (2002) Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 99:39713977.
  • 12
    Arya M, Kolomeisky AB, Romo GM, Cruz MA, Lopez JA, Anvari B (2005) Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand Factor. Biophys J 88:43914401.
  • 13
    Coburn LA, Damaraju VS, Dozic S, Eskin SG, Cruz MA, McIntire LV (2011) GPIb-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease. Biophys J 100:304312.
  • 14
    Yago T, Lou J, Wu T, Yang J, Miner JJ, Coburn L, López JA, Cruz MA, Dong JF, McIntire LV, McEver RP,[1, 9] Zhu C (2008) Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 118:31953207..
  • 15
    Auton M, Zhu C, Cruz MA (2010) The mechanism of VWF-mediated platelet GPIbalpha binding. Biophys J 99:11921201.
  • 16
    Auton M, Sedlak E, Marek J, Wu T, Zhu C, Cruz MA (2009) Changes in thermodynamic stability of von willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha. Biophys J 97:618627.
  • 17
    Emsley J, Cruz M, Handin R, Liddington R (1998) Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein Ib. J Biol Chem 273:1039610401.
  • 18
    Fukuda K, Doggett TA, Bankston LA, Cruz MA, Diacovo TG, Liddington RC (2002) Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure 10:943950.
  • 19
    Kim J, Zhang CZ, Zhang X, Springer TA (2010) A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature 466:992995.
  • 20
    Miyata S, Ruggeri ZM (1999) Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow. J Biol Chem 274:65866593.
  • 21
    Celikel R, Ruggeri ZM, Varughese KI (2000) von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule. Nat Struct Biol 7:881884.
  • 22
    Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P (2002) Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 297:11761179.
  • 23
    Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L (2004) Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem 279:2332723334.
  • 24
    Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri ZM, Zimmerman TS (1988) Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem 263:1790117904.
  • 25
    Fujimura Y, Usami Y, Titani K, Niinomi K, Nishio K, Takase T, Yoshioka A, Fukui H (1991) Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib. Blood 77:113120.
  • 26
    Celikel R, Varughese KI, Madhusudan, Yoshioka A, Ware J, Ruggeri ZM (1998) Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat Struct Biol 5:189194.
  • 27
    Ulrichts H, Udvardy M, Lenting PJ, Pareyn I, Vandeputte N, Vanhoorelbeke K, and Deckmyn H, (2006) Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem 281:46994707.
  • 28
    Auton M, Sowa KE, Behymer M, Cruz MA (2012) The N-terminal flanking region of A1 domain in Von Willebrand Factor stabilizes the structure of the A1A2A3 complex and modulates platelet activation under shear stress. J Biol Chem 287:1457914585.
  • 29
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J (1993) A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. J Clin Invest 91:273282.
  • 30
    Ulrichts H, Harsfalvi J, Bene L, Matko J, Vermylen J, Ajzenberg N, Baruch D, Deckmyn H, Tornai I (2004) A monoclonal antibody directed against human von Willebrand factor induces type 2Blike alterations. J Thromb Haemost 2:16221628.
  • 31
    Böhm G, Muhr R, Jaenicke R (1992) Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng 5:191195.
  • 32
    Auton M, Sowa KE, Smith SM, Sedlak E, Vijayan KV, Cruz MA (2010) Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress. J Biol Chem 285:2283122839.
  • 33
    Morales LD, Martin C, Cruz MA (2006) The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. J Thromb Haemost 4:417425.
  • 34
    Cruz MA, Diacovo TG, Emsley J, Liddington R, Handin RI (2000) Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain. J Biol Chem 275:1909819105.
  • 35
    Pace CN, Vajdos F, Fee L, Grimsley G, Gray T (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4:24112423.
  • 36
    Savitzky A, Golay MJE (1964) Smoothing and differentiation of data by simplifies least squares procedures. Anal Chem 34:16271639.
  • 37
    Auton M, Cruz MA, Moake J (2007) Conformational stability and domain unfolding of the von willebrand factor A domains. J Mol Biol 366:9861000.
  • 38
    Atkins PW, Chapter 25: the rates of chemical reactions. In: Atkins PW (1994) Physical chemistry, 5 ed. New York: W. H. Freeman and Company, pp. 861897.
  • 39
    Lyubarev AE, Kurganov BI (1998) Modeling of irreversible thermal protein denaturation at varying temperature. I. The model involving two consecutive irreversible steps. Biochemistry (Mosc) 63:434440.
  • 40
    Kurganov BI, Lyubarev AE, Sanchez-Ruiz JM, Shnyrov VL (1997) Analysis of differential scanning calorimetry data for proteins. Criteria of validity of one-step mechanism of irreversible protein denaturation. Biophys Chem 69:125135.
  • 41
    Rainville ED, Bedient PE, Chapter 2: Equations of Order One. In: (1989) Elementary differential equations, 7 ed. New York: Macmillan Publishing Company, pp. 1746.